Pricing

Three tiers. No per-back-test charges.

Cancel anytime. Billing in Korean Won (KRW) via KakaoPay or Korean credit card. USD equivalents shown for reference only.

Finology is a back-testing research subscription. You are paying for access to research tooling — not for investment advice, trade execution, or portfolio management services. Back-test results are not a guarantee of future returns.

Starter
무료 (Free)
forever
$0
  • 5 back-tests per month
  • KOSPI 200 universe only
  • 3-year data window (2021–2024)
  • Mid-price fill only (no slippage model)
  • CSV export only
  • Community forum access
Start Free
Most Popular
Analyst
₩29,000
per month (billed monthly)
~$21 USD
  • Unlimited back-tests
  • KOSPI 200 + KOSDAQ universe
  • Full 20-year data window (2005–present)
  • Lot-level slippage modeling
  • KRX dividend calendar alignment
  • Walk-forward validation (12-window)
  • PDF + JSON export
  • Email support
Start Analyst Trial
Professional
₩79,000
per month (billed monthly)
~$57 USD
  • Everything in Analyst
  • Custom factor upload (CSV ranking input)
  • Combinatorial purged cross-validation (CPCV)
  • Walk-forward validation (unlimited windows)
  • API access (JSON endpoints, rate-limited)
  • Batch back-testing (up to 50 strategies)
  • Priority email support (<24h)
  • Strategy versioning + audit trail
Start Professional Trial
FAQ

Pricing FAQ

Yes. Billing is in KRW via Korean payment methods (KakaoPay, credit card). USD approximate equivalents shown for reference at current exchange rate.
Yes. No annual commitment required. Monthly subscribers can cancel before the next billing cycle with no charge.
Contact us at [email protected] with institutional email verification. We offer a 50% discount for verifiable academic researchers studying Korean capital markets.
Yes, permanently. It is limited to give you a genuine feel for the platform before committing.
Korean credit/debit cards and KakaoPay. International cards planned for a future release. All billing is processed in KRW.
No. Finology is a back-testing research platform, not a financial investment adviser (투자자문업자) and not a brokerage (증권회사). We do not execute trades, manage portfolios, or provide personalised investment recommendations. Subscription fees are for research tool access only. You remain solely responsible for any investment decisions you make using output from the platform.

Not sure which tier? Start free.

The Starter plan has no time limit. Upgrade to Analyst when you need the full 20-year KOSPI data window and lot-level slippage modeling.

Start Back-Testing

Back-test results are not a guarantee of future returns. Finology is a research tool and does not provide investment advice or brokerage services.